- Home
- IRTC
as 10-04-2024 4:00pm EST
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Francisco |
| Market Cap: | 3.2B | IPO Year: | 2016 |
| Target Price: | $118.00 | AVG Volume (30 days): | 421.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $60.88 - $124.12 | Next Earning Date: | 10-31-2024 |
| Revenue: | $537,091,000 | Revenue Growth: | 18.81% |
| Revenue Growth (this year): | 21.25% | Revenue Growth (next year): | 17.93% |
Stock Insider Trading Activity of iRhythm Technologies Inc. (IRTC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bobzien Brice | IRTC | Chief Financial Officer | Aug 9 '24 | Sell | $70.34 | 1,372 | $96,506.48 | 24,428 | |
| Smith Mervin | IRTC | EVP Strategic Business Ops | Aug 2 '24 | Sell | $74.66 | 688 | $51,366.08 | 10,360 |
Latest iRhythm Technologies Inc. News
IRTC Breaking Stock News: Dive into IRTC Ticker-Specific Updates for Smart Investing
Zacks
22 days ago
iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls
Medical Device Network
23 days ago
iRhythm’s Zio ECG monitoring system secures Japanese regulatory approval
MT Newswires
24 days ago
iRhythm Technologies Secures Japanese Approval for EGC Monitoring Device
GlobeNewswire
24 days ago
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
Zacks
25 days ago
iRhythm Stock Gains Following Favorable Zio Monitor Study Data
Zacks
a month ago
iRhythm Stock May Gain on Its Latest Deal With BioIntelliSense
GlobeNewswire
a month ago
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
MT Newswires
a month ago
iRhythm Technologies Signs License Agreement With BioIntelliSense for Multiparameter Sensor Technology
Compare IRTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRTC iRhythm Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.